Pfizer and BioNTech announced details on collaboration to accelerate global COVID-19 vaccine development
On Apr. 9, 2020, Pfizer and BioNTech disclosed additional details of their collaboration to advance candidates from BioNTech’s…
-
-
Chembio Diagnostics and Stony Brook Medicine collaborated to identify Coronavirus survivors
On Apr. 9, 2020, Chembio Diagnostics has been selected for use in a Stony Brook Medicine effort to…
-
iBio announced signing of agreements with Infectious Disease Research Institute in support of iBio’s SARS-CoV-2 Virus-Like Particle vaccine development
On Apr. 9, 2020, iBio announced the signing of two agreements with the Infectious Disease Research Institute (IDRI)…
-
Gilead announced $20 million philanthropic fund to support nonprofit organizations impacted by the COVID-19 crisis
On Apr. 8, 2020, Gilead Sciences announced the creation of the global Gilead CARES (COVID-19 Acute Relief and…
-
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received EUA for its Smart Detect SARS-CoV-2 rRT-PCR Kit for detection of virus causing COVID-19
On Apr. 8, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
-
Mateon expanded its COVID-19 therapeutic program to include Artemisinin
On Apr. 8, 2020, Mateon Therapeutics announced that its COVID-19 directed antiviral screening program discovered that Artemisinin is…
-
Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
-
MediciNova announced plans to initiate a clinical trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
-
PharmaCyte Biotech entered into license agreement for COVID-19 diagnostic kits
On Apr. 8, 2020, PharmaCyte Biotech announced a license agreement with Hai Kang Life Corp. whereby PharmaCyte received…
-
Nanomix awarded BARDA contract for development of rapid, mobile, point-of-care assays to detect COVID-19
On Apr. 8, 2020, Nanomix announced that the company had been awarded $570,000 in funding from Biomedical Advanced…
-
Vanda Pharma and University of Illinois at Chicago announce partnership to identify novel antivirals against COVID-19
On Apr. 8, 2020, Vanda Pharmaceuticals and the University of Illinois at Chicago (UIC) announced a research partnership…
-
Pacific Biosciences powers SARS-CoV-2 research at commercial, academic and government labs
On Apr. 8, 2020, Pacific Biosciences announced it is working with commercial, academic and government research teams that…
-
Bellerophon Therapeutics submitted investigational NDA to study INOpulseﾮ inhaled nitric oxide for treatment of COVID-19
On Apr. 8, 2020, Bellerophon Therapeutics announced submission of an Investigational New Drug (IND) application to the FDA…
-
Chugai started phase III clinical trial of Actemra for COVID-19 pneumonia in Japan
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
-
CSL Behring and SAB Biotherapeutics joined forces to deliver new potential COVID-19 therapeutic
On Apr. 8, 2020, CSL Behring and SAB Biotherapeutics announced a partnership to combat the coronavirus pandemic with…
-
Philips and US government collaborate in ventilator production ramp up to combat COVID-19 pandemic
On Apr. 8, 2020, Philips announced that the U.S. Government and Philips agreed to team up to increase…
-
Abbott FreeStyleﾮ Libre 14 Day System available in US for hospitalized patients with diabetes during COVID-19 pandemic
On Apr. 8, 2020, Abbott announced that the FreeStyle Libre 14 day system, a continuous glucose monitoring (CGM)…
-
Arizona COVID-19 Genomics Union to track the virus
On Apr. 8, 2020, TGen, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern…
-
Karyopharm to evaluate low dose Selinexor as potential treatment for hospitalized patients with COVID-19
On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…
-
Repurposing existing drugs could offer faster path to COVID-19 treatment
On Apr. 7, 2020, a map of interactions between the novel coronavirus and human proteins is helping scientists…
-
Pluristem reported preliminary data from COVID-19 Compassionate Use Program, treating seven patients with acute respiratory failure
On Apr. 7, 2020, Pluristem Therapeutics announced preliminary data from its compassionate use program, treating seven patients suffering…
-
Queensland University leads international team researching ancient Australian plant to help in production of COVID-19 vaccine
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
-
Cumberland Pharma expanded availability of Vaprisol to treat Hyponatremia for critical care COVID-19 patients
On Apr. 7, 2020, Cumberland Pharma announced an initiative to increase availability of Vaprisol (conivaptan hydrochloride) injection for…
-
Mesa Biotech to ship 10,000 Accula SARS-CoV-2 tests for 30 minute rapid molecular point of care diagnosis
On Apr. 7, 2020, Mesa Biotech announced it was shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point…
-
FDA approved Emory University human clinical trials for Emory COVID-19 antiviral
On Apr. 7, 2020, the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug application by…
-
Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
On Apr. 7, 2020, researchers at the University of Iowa and the University of Georgia announced they had…
-
Harvard, MIT and Stanford commited to COVID-19 technology licensing principles, maximizing access to innovations
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Rice University established COVID-19 research fund
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
-
Mateon achieved milestone in development of OT-101, a phase 3 clinical drug candidate, against COVID-19
On Apr. 6, 2020, Mateon Therapeutics announced that it has delivered the requisite testing results to Golden Mountain…
-
OncoSec collaborated with Providence Cancer Institute to conduct first-in-human trial of CORVax12, an Investigational Vaccine to prevent COVID-19
On Apr. 6, 2020, OncoSec Medical announced that Providence Cancer Institute, a part of Providence St. Joseph Health…
![Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers](https://lifesciencehistory.com/wp-content/uploads/2024/05/dynavax_logo-3.png){kind=logo}
